Federated Hermes’s Athira Pharma ATHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-831
Closed -$237 2066
2025
Q1
$237 Sell
831
-183
-18% -$52 ﹤0.01% 2038
2024
Q4
$595 Sell
1,014
-14,048
-93% -$8.24K ﹤0.01% 2037
2024
Q3
$6.72K Sell
15,062
-211
-1% -$94 ﹤0.01% 1834
2024
Q2
$40.5K Buy
15,273
+671
+5% +$1.78K ﹤0.01% 1634
2024
Q1
$40K Buy
14,602
+554
+4% +$1.52K ﹤0.01% 1634
2023
Q4
$34.1K Sell
14,048
-881
-6% -$2.14K ﹤0.01% 1691
2023
Q3
$30.2K Sell
14,929
-4,733
-24% -$9.56K ﹤0.01% 1732
2023
Q2
$58K Buy
19,662
+9,081
+86% +$26.8K ﹤0.01% 1658
2023
Q1
$26.5K Buy
10,581
+3,994
+61% +$9.99K ﹤0.01% 1790
2022
Q4
$20.9K Buy
6,587
+3,284
+99% +$10.4K ﹤0.01% 1799
2022
Q3
$10K Buy
3,303
+2,615
+380% +$7.92K ﹤0.01% 1830
2022
Q2
$2K Buy
+688
New +$2K ﹤0.01% 1964